Lawrence G. Hamel, Chief Development Officer at ACELRX PHARMACEUTICALS INC (ACRX), sold 5,216 shares at $5.00 ($26K) on 2018-10-15, disclosed to the SEC on 2018-10-16.
Scheduled sale ($26k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACRX | SELL | 2017-10-03 | $108K | — | Filing → |